Indiana Poison Center reports GLP-1 calls doubled last year. National Poison Data System, America's Poison Centers reports a 1,500% increase in GLP-1 related calls.

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

Kayshild is recommended for adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis and ...

Association driven by fewer major amputations ...

GLP-1 weight-loss drugs offer promising results but come with potential risks and unknown long-term effects, emphasizing the ...

Some patients have pointed to severe undisclosed side effects, including blindness, loss of brain function and organ damage.

Lawsuits continue against makers of GLP-1 weight-loss drugs over side effects ranging from extreme vomiting to what some ...

Winfrey has openly discussed her weight-loss journey and the use of prescription GLP-1 medications in recent years.

Participating Medicare Part D plans can officially begin covering weight-loss treatment in 2027. The initiative falls under CMS’ voluntary “Better Approaches to Lifestyle and Nutrition for ...

GLP-1 drugs might lead people to shun alcohol entirely: or the effect may be more nuanced. People might have one drink to ...

Poison control calls involving GLP-1 medications like semaglutide and tirzepatide have dramatically risen in recent years.

This session pulls back the curtain on creative funding strategies designed to de-risk GLP-1 coverage, allowing you to bring ...